300119.SZ
瑞普生物
SZSE · Healthcare · C 制造业 · CN
CNY 17.34
−3.24%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- —
- Revenue estimate
- CNY 925.0M
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- CNY 0.21
- EPS estimate
- —
- Revenue actual
- CNY 884.5M
- Revenue estimate
- CNY 894.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026